← All trials
NCT01576783
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2012
- Primary completion
- Mar 1, 2017
- Completion date
- Apr 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 448
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ohio State UniversityLead sponsor
- Ohio State UniversityOverall official - principal investigator
- Ohio State UniversitySponsor investigator
- Allen Foundation Inc.Collaborator
- March of DimesCollaborator
- Cures Within ReachCollaborator
- Health Resources and Services Administration (HRSA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.